Manuela Aguilar-Guisado

Manuela Aguilar-Guisado


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2007 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MAManuela Aguilar-Guisado
Manuela Aguilar-Guisado
JGJ Givaldá
J Givaldá
PUP Ussetti
P Ussetti
ARA Ramos
A Ramos
PMP Morales
P Morales
RCResitra Cohort
Resitra Cohort
The aim of the present study is to evaluate the epidemiology, etiology and prognosis of pneumonia in lung transplant (LT) recipients. This is a prospective, multicenter study of a consecutive cohort of LT recipients in Spain. From September 2003 to November 2005, 85 episodes of pneumonia in 236 LT recipients were included (incidence 72 episodes per 100 LT/year). Bacterial pneumonia (82.7%) was more frequent than fungal (14%) and viral pneumonia (10.4%). The most frequent microorganisms in each etiological group were Pseudomonas aeruginosa (n = 14, 24.6%), CMV (n = 6, 10.4%) and Aspergillus spp. (n = 5, 8.8%). Incidence of Aspergillus spp. and CMV pneumonia is lower than previously reported, probably due to the spread of universal prophylaxis. Pneumonia caused by viruses appeared significantly later than pneumonia due to gram‐negative bacilli, fungi and those without known etiology (p < 0.01, p = 0.03 and p = 0.02, respectively). The routine use of ganciclovir has changed the natural history of CMV infection, so that pneumonia appears later, once prophylaxis is suspended. The probability of survival during the first year of follow‐up was significantly higher in the multivariate analysis in LT recipients who did not have a pneumonia episode compared with those that had at least one episode (p < 0.01).

21 August 2011 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MAManuela Aguilar-Guisado
Manuela Aguilar-Guisado
MJMargarita Jiménez-Jambrina
Margarita Jiménez-Jambrina
IEIldefonso Espigado
Ildefonso Espigado
MRMontserrat Rovira
Montserrat Rovira
RMRodrigo Martino
Rodrigo Martino
JUJulián
Julián

17 November 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
AGAna Belen Guisado-Gil
Ana Belen Guisado-Gil
CICarmen Infante-Domínguez
Carmen Infante-Domínguez
GPGermán Peñalva
Germán Peñalva
JPJulia Praena
Julia Praena
CRCristina Roca
Cristina Roca
OTOn behalf of the PRIOAM Team
On behalf of the PRIOAM Team
During the COVID-19 pandemic, the implementation of antimicrobial stewardship strategies has been recommended. This study aimed to assess the impact of the COVID-19 pandemic in a tertiary care Spanish hospital with an active ongoing antimicrobial stewardship programme (ASP). For a 20-week period, we weekly assessed antimicrobial consumption, incidence density, and crude death rate per 1000 occupied bed days of candidemia and multidrug-resistant (MDR) bacterial bloodstream infections (BSI). We conducted a segmented regression analysis of time series. Antimicrobial consumption increased +3.5% per week (p = 0.016) for six weeks after the national lockdown, followed by a sustained weekly reduction of −6.4% (p = 0.001). The global trend for the whole period was stable. The frequency of empirical treatment of patients with COVID-19 was 33.7%. No change in the global trend of incidence of hospital-acquired candidemia and MDR bacterial BSI was observed (+0.5% weekly; p = 0.816), nor differences in 14 and 30-day crude death rates (p = 0.653 and p = 0.732, respectively). Our work provides quantitative data about the pandemic effect on antimicrobial consumption and clinical outcomes in a centre with an active ongoing institutional and education-based ASP. However, assessing the long-term impact of the COVID-19 pandemic on antimicrobial resistance is required.

15 June 2009 in Bone Marrow Transplantation
Verified
Journal Article
Open access
MAManuela Aguilar-Guisado
Manuela Aguilar-Guisado
IEI Espigado
I Espigado
MMMaría Elisa Cordero Matía
María Elisa Cordero Matía
MNM Noguer
M Noguer
RPR Parody
R Parody
JCJosé M. Cisneros
José M. Cisneros
Universal empirical antifungal therapy (EAT) in patients with unexplained persistent febrile neutropenia (PFN) is the standard of care, but EAT could be applied in selected patients on the basis of clinical criteria and risk factors. A prospective interventional study was carried out to analyse the incidence and related mortality of invasive fungal infection (IFI) in patients with PFN according to whether or not EAT was indicated. EAT was indicated according to the following criteria: (a) severe sepsis or septic shock; (b) focused infection: lung, central nervous system, sinus, abdominal or skin; (c) individualized clinical decision in patients at high risk. Sixty-six (19%) of 347 episodes of febrile neutropenia fulfilled PFN criteria, 97% with a haematological malignancy. Just 26 (39.4%) were treated with EAT. The overall IFI incidence was 4.5%. In the group that received EAT, three patients developed IFI (11.5%), in comparison with none in the group that did not receive it (P=0.04, RR 2.7:1.9–3.8). IFI-related mortality was null in the group that did not receive EAT and 8% (two of 26 patients) in the group that received EAT. These data suggest that in patients with PFN, EAT in selected patients may be safe and avoid unnecessary antifungal therapy.

11 July 2023 in Emerging Microbes & Infections
Verified
Journal Article
Open access
PMPatricia Mingo-Casas
Patricia Mingo-Casas
JSJavier Sanchez-Cespedes
Javier Sanchez-Cespedes
ABAna B Blazquez
Ana B Blazquez
JCJosefina Casas
Josefina Casas
MBMaría Balsera-Manzanero
María Balsera-Manzanero
Miguel Martin-AcebesMiguel Martin-Acebes
Miguel Martin-Acebes
West Nile virus (WNV) is a neurotropic flavivirus transmitted by the bites of infected mosquitoes. Severe forms of West Nile disease (WND) can curse with meningitis, encephalitis or acute flaccid paralysis. A better understanding of the physiopathology associated with disease progression is mandatory to find biomarkers and effective therapies. In this scenario, blood derivatives (plasma and serum) constitute the more commonly used biofluids due to its ease of collection and high value for diagnostic purposes. Therefore, the potential impact of this virus in the circulating lipidome was addressed combining the analysis of samples from experimentally infected mice and naturally WND patients. Our results unveil dynamic alterations in the lipidome that define specific metabolic fingerprints of different infection stages. Concomitant with neuroinvasion in mice, the lipid landscape was dominated by a metabolic reprograming that resulted in significant elevations of circulating sphingolipids (ceramides, dihydroceramides, and dihydrosphingomyelins), phosphatidylethanolamines and triacylglycerols. Remarkably, patients suffering from WND also displayed an elevation of ceramides, dihydroceramides, lactosylceramides, and monoacylglycerols in their sera. The dysregulation of sphingolipid metabolism by WNV may provide new therapeutic opportunities and supports the potential of certain lipids as novel peripheral biomarkers of WND progression.

15 November 2023 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
ACAna Casado
Ana Casado
AGAdelina Gimeno
Adelina Gimeno
MAManuela Aguilar-Guisado
Manuela Aguilar-Guisado
MGManuel García
Manuel García
JRJesús Francisco Rodríguez
Jesús Francisco Rodríguez
JMJosé Molina
José Molina
This study evaluates the safety of early oral ambulatory treatment of adult patients diagnosed with bacteremia after their discharge from the emergency department. A cohort of 206 febrile ambulatory patients was assessed. Bacteremic low-risk patients were recommended an oral treatment and were compared with matched febrile non-bacteremic outpatients. Rates of 14-day mortality and unplanned re-consultations were similar and below 5% in both cohorts, highlighting the safety of oral therapy of low-risk bacteremia, even from its onset.